![Steve Lebow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steve Lebow
No más puestos en curso
Perfil
Steve Lebow is Chief Medical Officer of Orasi Medical, Inc. Previously, Dr. Lebow served as Clinical Research Director of Noran Clinic.
He has over 30 years of experience in clinical practice.
Dr Lebow received an MD from the University of Minnesota.
Antiguos cargos conocidos de Steve Lebow.
Empresas | Cargo | Fin |
---|---|---|
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Director Técnico/Científico/I+D | 18/08/2012 |
Minnesota Department of Labor & Industry | Corporate Officer/Principal | - |
Formación de Steve Lebow.
University of Minnesota | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Minnesota Department of Labor & Industry |
- Bolsa de valores
- Insiders
- Steve Lebow